William D. Gwynne

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Investigation of the mesencephalic astrocyte-derived neurotrophic factor-endoplasmic reticulum stress pathway in mood disorders.

Investigation of the mesencephalic astrocyte-derived neurotrophic factor-endoplasmic reticulum stress pathway in mood disorders.

Journal: The international journal of neuropsychopharmacology

Published: July 16, 2024

Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing.

Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing.

Journal: Haematologica

Published: June 05, 2024

De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases.

De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases.

Journal: Cell reports. Medicine

Published: December 11, 2023

Correction to: Dynamic profiling of medulloblastoma surfaceome.

Correction to: Dynamic profiling of medulloblastoma surfaceome.

Journal: Acta neuropathologica communications

Published: October 23, 2023

Protocol for mapping the metabolome and lipidome of medulloblastoma cells using liquid chromatography-mass spectrometry.

Protocol for mapping the metabolome and lipidome of medulloblastoma cells using liquid chromatography-mass spectrometry.

Journal: STAR protocols

Published: July 18, 2023

Dynamic profiling of medulloblastoma surfaceome.

Dynamic profiling of medulloblastoma surfaceome.

Journal: Acta neuropathologica communications

Published: April 20, 2023

Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.

Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.

Journal: Nature communications

Published: January 10, 2023

Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma.

Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma.

Journal: Cancer cell

Published: June 26, 2022

The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.

The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.

Journal: Acta neuropathologica

Published: May 05, 2022

Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma.

Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma.

Journal: Journal of medicinal chemistry

Published: February 04, 2022

Childhood Medulloblastoma: An Overview.

Childhood Medulloblastoma: An Overview.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 03, 2022

Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.

Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.

Journal: Science advances

Published: December 08, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026